Skip to main content

Month: September 2021

SOPHiA GENETICS Reports Second Quarter 2021 Financial Results and Issues 2021 Guidance

BOSTON and LAUSANNE, Switzerland, Sept. 09, 2021 (GLOBE NEWSWIRE) — SOPHiA GENETICS SA (NASDAQ: SOPH), today reported financial results for the three months ended June 30, 2021. Recent HighlightsRevenue was $10.2 million for the second quarter, representing a 72% increase over the corresponding period of 2020 Increased total customer base of hospitals, labs, and biopharma institutions to 780 customers during the second quarter, up from 750 in the first quarter of 2021 Strengthened balance sheet by raising approximately $217 million in net proceeds from the initial public offering in July 2021 and an additional $20 million in gross proceeds from a private placement investment from an affiliate of GE Healthcare Expanded partnership with DASA, the largest integrated healthcare network in Brazil, to offer the first decentralized...

Continue reading

Tuesday Morning Corporation Announces Fiscal 2021 Results; Enhances Management Team With New Hires Across Key Areas of Organization

DALLAS, Sept. 09, 2021 (GLOBE NEWSWIRE) — Tuesday Morning Corporation (NASDAQ: TUEM), a leading off-price retailer of home goods and décor, today announced its results for the fourth quarter and full year fiscal 2021 ended June 30, 2021. In addition, the Company announced the appointment of Marc Katz as Principal and Chief Operating Officer, Jennifer Robinson as Chief Financial Officer and Bill Baumann as Chief Information Officer. Fred Hand, Chief Executive Officer, stated, “I am proud of the Tuesday Morning team’s hard work and dedication over the past year emerging from bankruptcy with a strong liquidity position. I am very pleased to continue to work with Marc in his new role and welcome Jennifer and Bill to the team. We have been able to fill key leadership roles that will enhance our existing strong team. With our experienced...

Continue reading

IVD Market Size | Is Projected to Grow USD 153.67 Billion in 2028 at a CAGR of 6.9%

Key Prominent Players Covered in the In vitro Diagnostic Market Research Report Are Hoffmann-La Roche Ltd, Abbott Laboratories, Thermo Fisher Scientific Inc., Sysmex Corporation, Siemens Healthineers AG, BD, Seegene Inc., DiaSorin S.p.A., Quest Diagnostics Incorporated Pune, India, Sept. 09, 2021 (GLOBE NEWSWIRE) — The IVD Market size was USD 82.81 billion in 2020. The market is projected to grow from USD 96.13 billion in 2021 to USD 153.67 billion in 2028 at a CAGR of 6.9% during the 2021-2028 period. This vital information is published by Fortune Business Insights™ in its report titled, “IVD Market, 2021-2028.” As per our research, the intensifying demand for point-of-care IVD devices and the growing adoption of these apparatuses have been contributory in navigating the growth of the market. Additionally, as per the British In-vitro...

Continue reading

Comstock Acquires Plain Sight Innovations Corporation

Extensive Portfolio of Pioneering Clean Technologies; Cellulosic Biofuels VIRGINIA CITY, Nev., Sept. 09, 2021 (GLOBE NEWSWIRE) — Comstock Mining Inc. (NYSE: LODE) (“Comstock” and the “Company”) today announced its acquisition of 100% of the issued and outstanding equity of Plain Sight Innovations Corporation (“PSI”) in exchange for 8,500,000 restricted shares of its common stock, and all of the intellectual property assets of PSI’s affiliate, FLUX Photon Corporation (“FPC”), in exchange for a performance-based cash payment equal to 20% of the Company’s future consolidated net cash flow from operations up to $18,000,000. PSI’s management team has deep experience in a diverse array of industries, including renewable fuels, hazardous waste, agriproducts, and other commodities with almost thirty years of clean technology research,...

Continue reading

Teleflex Unveils the UroLift Advanced Tissue Control (ATC)® System and the UroLift® 2 System and Real-World Data Presentations at the American Urological Association 2021 Annual Meeting

New real-world data findings along with new product evolutions demonstrate why the UroLift® System is the right solution for most BPH patients WAYNE, Pa., Sept. 09, 2021 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX) today announced that two new UroLift System products, the UroLift Advanced Tissue Control (ATC) System and the UroLift 2 System, will be launched at the American Urological Association (AUA) 2021 Annual Meeting taking place virtually September 10–13. New emerging data from the largest analysis of U.S. healthcare claims within the field of benign prostatic hyperplasia (BPH) comparing complication rates (defined as a post-operative procedure performed during a return visit to an outpatient setting) and surgical retreatment rates of BPH procedures, including the UroLift System, will also be presented. The UroLift...

Continue reading

Immuneering Reports Second Quarter 2021 Financial Results and Provides Business Updates

Recently completed upsized initial public offering raising $129.4 million in gross proceeds, providing runway into 2024 Company expects to file IND for IMM-1-104 in Q1 2022 CAMBRIDGE, Mass., Sept. 09, 2021 (GLOBE NEWSWIRE) — Immuneering Corporation (Nasdaq: IMRX), a biopharmaceutical company advancing a robust pipeline of oncology and neuroscience product candidates that are designed to uniquely disrupt cellular signaling dynamics, today reported financial results for the second quarter ended June 30, 2021 and provided a corporate update. “We continue to make significant progress across all aspects of our organization and with the recent IPO proceeds and the additions to our management team and board of directors, we plan to advance our pipeline and strive to bring novel medicines to patients,” said Ben Zeskind, chief executive...

Continue reading

Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences

RESEARCH TRIANGLE PARK, N.C., Sept. 09, 2021 (GLOBE NEWSWIRE) — Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a specialty pharmaceutical company focused on the development of PEDMARK™ (a unique formulation of sodium thiosulfate) for the prevention of platinum-induced ototoxicity in pediatric patients, today announced that management will participate in three upcoming virtual investor conferences, including H.C. Wainwright 23rd Annual Global Investment Conference taking place September 13-15, 2021, the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit taking place September 20-23, 2021, and the 2021 Cantor Virtual Global Healthcare Conference taking place September 27-30, 2021. H.C. Wainwright 23rd Annual Global Investment ConferenceSeptember 13-15, 2021Format: Company presentation (available September 13 at...

Continue reading

New Cybersecurity Report from HP Reveals 91% of IT Teams Feel Pressure to Compromise Security

Securing the growing hybrid workplace presents exponential threat landscape PALO ALTO, Calif., Sept. 09, 2021 (GLOBE NEWSWIRE) — HP Inc. (NYSE: HPQ) today released its HP Wolf Security Rebellions & Rejections report, a comprehensive global study highlighting the tension between IT teams and employees working from home (WFH) that security leaders must resolve in order to secure the future of work. The findings show that IT teams have been forced into compromising security for business continuity at a time of rising threats. Making matters worse, their attempts to increase or update security measures for remote workers have often been rejected. This is particularly true for the future workforce of 18-24-year-olds – digital natives who feel increasingly frustrated with security getting in the way of deadlines, leading many to...

Continue reading

Sumo Logic Adds Margaret Francis to its Board of Directors

Francis Brings Modern Software Development and Product Led Growth Expertise to Help Company Drive Continuous Intelligence Category Leadership REDWOOD CITY, Calif., Sept. 09, 2021 (GLOBE NEWSWIRE) — Sumo Logic, (Nasdaq: SUMO), the pioneer in continuous intelligence, today announced the appointment of Margaret Francis to its board of directors as an independent board member to help the Company further serve the burgeoning DevSecOps market opportunity. “Over the last several years we have made a number of investments to further expand our DevSecOps platform strategy and increase our relevance with the teams that are driving digital transformation within their organizations,” said Ramin Sayar, president and CEO, Sumo Logic. “Margaret brings a deep and unique perspective to product strategy, taking a developer-first, end-user approach...

Continue reading

Kraken Receives $0.8 Million Sensor Order from New Fortune 500 Customer

ST. JOHN’S, Newfoundland and Labrador, Sept. 09, 2021 (GLOBE NEWSWIRE) — Kraken Robotics Inc. (TSX-V: PNG, OTCQB: KRKNF), Canada’s Ocean Company™, is pleased to announce an order for an AquaPix® MINSAS 120 sonar system from a Fortune 500 company with activities in the defense sector. Total contract value is approximately $765,000. This is a new Kraken customer and due to the nature of this customer’s business, Kraken cannot disclose further details. The Company expects to fulfill this order in Q1/2022. Kraken’s AquaPix® MINSAS is an off the shelf configurable Synthetic Aperture Sonar (SAS) which replaces high end sidescan systems at an affordable price, while delivering significantly higher resolution, range, and area coverage rates (ACR). The increased range and resolution and associated higher ACR of Synthetic Aperture Sonar...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.